Effects of antimicrobial drug shortages [3]

American Journal of Health-System Pharmacy

Volumn 62, Issue 14, 2005, Pages 1444-

  Ferrández, Olivia ^a,b   Mateu De Antonio, Javier ^a,b   Grau, Santiago ^b  

^a Hospital Pharmacy   (Spain)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIINFECTIVE AGENT; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BUDGET; DRUG COST; ECONOMIC ASPECT; HEALTH CARE DELIVERY; HOSPITAL INFECTION; HOSPITAL PHARMACY; HUMAN; INFECTION; LETTER; MYCOSIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY;

EID: 84860967689     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp050009     Document Type: Letter

References (5)

1. Fox ER, Tyler LS. Measuring the impact of drug shortages. Am J Health-Syst Pharm. 2004; 61:2009. Editorial.
2. Baumer AM, Clark AM, Witmer DR et al. National survey of the impact of drug shortages in acute care hospitals. Am J Health-Syst Pharm. 2004; 61:2015-22.
3. Grau S, Marin M, Ferrandez O et al. Amphotericin B deoxycholate shortage: drug budget in distress. Paper presented at 44th International Conference on Antimicrobial Agents and Chemotherapy. Washington, DC; 2004 Nov 1.
4. Bosso JA, Kokko H. Assessment of the impact of an antibiotic shortage: patient outcomes and costs. Hosp Pharm. 2004; 39:43-6.
5. Grau S, Vila J, Marin M et al. Piperacillin-tazobactam shortage: influence in the resistance level to this antibiotic of nosocomial P. aeruginosa strains isolated from in-patients blood cultures. Paper presented at 44th International Conference on Antimicrobial Agents and Chemotherapy. Washington, DC; 2004 Nov 1.